Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022

SELL
$86.01 - $102.89 $303,787 - $363,407
-3,532 Closed
0 $0
Q3 2021

Nov 05, 2021

BUY
$84.7 - $96.31 $299,160 - $340,166
3,532 New
3,532 $309,000
Q4 2019

Feb 06, 2020

SELL
$48.0 - $59.55 $1.9 Million - $2.36 Million
-39,687 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$46.64 - $55.39 $129,379 - $153,651
-2,774 Reduced 6.53%
39,687 $2.11 Million
Q2 2019

Aug 01, 2019

BUY
$40.81 - $52.42 $90,067 - $115,690
2,207 Added 5.48%
42,461 $0
Q4 2018

Jan 30, 2019

SELL
$36.49 - $51.72 $11,786 - $16,705
-323 Reduced 0.8%
40,254 $1.58 Million
Q2 2018

Jul 18, 2018

BUY
$35.0 - $48.9 $64,680 - $90,367
1,848 Added 4.77%
40,577 $0
Q1 2018

May 08, 2018

BUY
$31.7 - $44.1 $1.23 Million - $1.71 Million
38,729 New
38,729 $0

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Pendal Group LTD Portfolio

Follow Pendal Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.